Discover UTHEVER® NMN’s Global Regulatory Landscape

Overview


Effepharm

NMN has long faced regulatory challenges. Today, that landscape is changing. We consistently invest in scientific research & quality development, aiming to establish UTHEVER® as the world’s most compliant NMN ingredient brand.

Now, UTHEVER® has obtained regulatory recognition in the USA, EU & Brazil, and NMN is already compliantly sold in Mexico, Japan, HK & Malaysia. We actively pursue compliance in more Asia‑Pacific markets. This is our commitment to product quality and long-term global compliance. UTHEVER® NMN with a global compliance passport offers a competitive edge for your global expansion.

Download the White Paper to discover where NMN is compliant today, access UTHEVER®’s official regulatory documents & global compliance progress.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

Paid for by Effepharm Ltd

White Paper

On 11th May 2026, EFSA officially published a positive scientific opinion on EffePharm’s β-NMN as a novel food. This is the first-ever EU official safety endorsement for NMN. UTHEVER® is the 1st NMN ingredient brand to receive EFSA’s positive opinion.

Uthever® NMN: Novel Food Approval Nearing Final Stage

Uthever® NMN: Novel Food Approval Nearing Final Stage

Paid for by Effepharm Ltd

White Paper

One Step Away from EU Market Compliance for NMN. The official positive opinion of Novel Food is expected to be published shortly, which means Uthever® NMN will be the first compliant ingredient.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.